Living Labs In Clinical Research: current status, challenges & future perspectives
A lot of Health and Wellbeing LLs are operating in various settings and infrastructures such as clinical setting, lab environments, distributed setting (e.g. homes, care centers) and also engaging various stakeholders from the quadruple helix in all processes. LLs also include innovative methodologies and an agile, user-centric view on designing and validating interventions.
Clinical trials are designed to answer specific questions about biomedical or behavioral interventions, including new treatments and should have clear and well-structured outcomes about efficacy, safety, efficiency, effectiveness and more and follow specific regulations. Depending on product type and development stage, investigators initially enroll volunteers or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. These are some of the questions that will be addressed during this panel.
10.00 – 10.05 Welcome and objectives – Despoina Petsani & Evdokimos Konstantinidis
10.05 – 10.15 The objectives of Health and Wellbeing AOTF – Panos Bamidis
10.15 – 11.05 Panel discussion moderated by HOLTEL Andreas (senior administrator
responsible for the majority of current health infrastructures projects, REA C.4)
● Jacques Demotes, Director General of the European Clinical Research Infrastructure
● Nico Gariboldi, Site Lead – Global Center for Digital Innovation – Senior Director at
Pfizer, Rome Area, Italy
● Ingrid Adriaensen, Businesses and Organizations innovation manager, Health Living
Labs, LicaLab, ThomasMore
● Hadas Lewy, Head of Digital Health Ventures Research, Innovation and International
Ventures Authority, Digital Medical Technology Department, Holon Institute of
● Jan-Willem van de Loo, Policy and Scientific Officer at the European Commission in charge of cancer
11.05 – 11.15 Q&A
Microbial geneticist in several EU countries
Andreas HoltelMicrobial geneticist in several EU countries
Andreas HOLTEL worked as microbial geneticist in several EU countries, before moving into institutional grant management at the Helmholtz Centre for Infection Research (HZI) in Germany. In 2001 he joined the EU Commission DG RTD Health Research, dealt with malaria, vaccines, and later brain research. In between, and again since 2019, he takes care of life sciences research infrastructures under the H2020, and now the Horizon Europe programmes’ parts on research infrastructure support. He is currently seconded to the European Executive Research Agency, also placed in Brussels, which has taken over the management of respective EU funded research projects as from April 2021.
Laurea University Director
Tuija HirvikoskiLaurea University Director
Dr Tuija Hirvikoski is currently a director at Laurea University of Applied Sciences responsible for the University’s strategic stakeholder management. During her Vice-Presidency, Laurea become Finland’s most successful University of Applied Sciences receiving multiple awards. She has held managerial positions at various Finnish higher education institutions and governmental institutions focusing on sustainable regional and societal development. Hirvikoski’s specific area of expertise is related to multi-stakeholder, user-centred innovation design and ecosystem development (Living Labs). She has received a PhD in Industrial Management (Innovation and Innovation Ecosystems), MSc in Education and MSc in Administration. As a sought-after advisor, she has provided various audiences with inspirational examples and research results concerning the Finnish education and open innovation ecosystems. Hirvikoski was the President of The European Network of Living Labs between 2015-2018 and has served as a council member in various organisations such as the Uusimaa Regional Coordination Committee, Sendai-Finland Wellbeing Centre R&D Unit, Tech villa Ltd (a Finnish technology centre), Helsinki Information Technology Association, the Talent Cultivation Program for Smart Living Industry in Taiwan, and the Centre for Skills and Post-Secondary Education (SPSE) in Canada.
Postdoctoral Research Associate, Thess-AHALL Researcher, AOTF Health & Wellbeing lead
Evdokimos KonstantinidisPostdoctoral Research Associate, Thess-AHALL Researcher, AOTF Health & Wellbeing lead
Dr Evdokimos Konstantinidis is the leader of the Assistive Technologies and Silver Science Research Group in the Lab of Medical Physics, Aristotle University of Thessaloniki. He received the Diploma in electronic engineering from the Technological Educational Institute of Thessaloniki, in 2004, the M.Sc. degree in medical informatics in 2008 from the Aristotle University of Thessaloniki, Greece and the Ph.D. degree in the Laboratory of Medical Physics of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Greece in 2015. His research interests lie predominately in the area of medical informatics, particularly within assistive technologies (silverscience, silvergaming, mobile health)
Despoina PetsaniResearch Assistant
Despoina Petsani received her diploma in Electrical and Computer Engineering in 2017 from Aristotle University of Thessaloniki, Greece. Her thesis was part of the iPrognosis project (H2020). She is currently a postgraduate student in Medical Informatics MSc program and Research Assistant in the Assistive Technologies and Silver Science Research Group in the Lab of Medical Physics, Medical School of Aristotle University of Thessaloniki where she is working in CAPTAIN project (H2020). Her research interests lie in the area of silver science and the intervention for older adults and vulnerable population in the field of serious games and medical decision support systems
Professor, Aristotle University of Thessaloniki
Panagiotis BamidisProfessor, Aristotle University of Thessaloniki
Panagiotis Bamidis is a Professor of Medical Physics, Informatics and Medical Education and Director of the Lab of Medical Physics and Digital Innovation in the School of Medicine of the Aristotle University of Thessaloniki (AUTH), Greece. He designs, implements and evaluates IT and Assistive Technologies systems that improve everyday activities of elderly or other vulnerable groups and improves their health or life quality or improves the education and training of health professionals. He conducts research that attempts to understand how the brain reacts to different stimuli, technological or educational interventions, as well as, the development and evolution of human emotions and sleep transitions. Co-creation and Living Lab approaches are within his active interests. He is the co-ordinator of seven large European projects, and the principal investigator for many national and international funded projects. He is the President of the Hellenic Biomedical Technology Society, HL7 Hellas, the international Society of Applied Neuroscience, a member of the Administration Boards of other societies and patient associations, the Chairman/Organiser of some 19 international conferences and several national Biomedical Technology conferences. Since 2012 he has established LLM Care ecosystem (www.llmcare.gr), the business exploitation of the LLM project, which is a two-star reference site of the EIP-on-AHA. In 2013 he established the Active and Healthy Ageing Living Lab in Thessaloniki (ThessAHALL; http://www.aha- livinglabs.com/) which in 2018 became a full member of the European Network of Living Labs (ENoLL). In 2017, he became a visiting Professor of Medical Education Technology, Innovation and Change for the Leeds Institute of Medical Education (LIME) of the University of Leeds, UK. He received Prizes for the Best Track Record in funded research projects (AUTH Research Committee 2009; AUTH Dean of Health Sciences 2016) and the Best overall high/extra-ordinary academic performance (AUTH Dean of Health Sciences 2018, 2019, 2020).
Site Lead - Global Center for Digital Innovation - Senior Director at Pfizer, Rome Area, Italy
Nico GariboldiSite Lead - Global Center for Digital Innovation - Senior Director at Pfizer, Rome Area, Italy
Site Lead - Global Center for Digital Innovation - Senior Director at Pfizer, Rome Area, Italy
Director general of the European Clinical Research Infrastructure Network
Jacques DemotesDirector general of the European Clinical Research Infrastructure Network
Jacques Demotes is the director general of the European Clinical Research Infrastructure Network (ECRIN), which he founded in 2004. In this role, he is responsible for the strategy and overall management of the infrastructure with the support of the ECRIN Management Office (located in Paris, France), the ECRIN European Correspondents (located in each Member / Observer country), and ECRIN’s Scientific Partners (i.e., national networks of clinical trial units). A neurologist and professor of cell biology, Demotes is an advisor to the biology and health research department at the French Ministry of Higher Education and Research. While at ECRIN, he has contributed to numerous initiatives and collaborative projects related to multinational clinical trials. In particular, he chaired the working group that drafted the Organisation for Economic Co-operation and Development (OECD) Council Recommendation on the Governance of Clinical Trials. Prior to ECRIN, he worked as a clinical neurologist and basic neuroscientist, then as director of the clinical investigation centre in Bordeaux. Demotes received his MD (with a specialisation in neurology), a PhD in neuroscience, a Master of Science (MS) in neuroscience, and a Bachelor of Arts (BA) in mathematics and computer science from the University of Bordeaux. He also received an MBA from IAE Paris, and completed a training course in science policy with the Institute of Advanced Studies in Science and Technology in Paris.
Ingrid AdriaensenLiCalab/Thomas More
Ingrid holds master degrees in communication and business management. She has a large experience working within international companies and organisations inside and outside Europe. At LiCalab, a health living lab, Ingrid supports businesses and organisations to bring health and care innovations to the market. She supports the development and execution of (international) living lab studies with main focus areas care technology, assisted living, active and healthy aging, patient rehabilitation and mental health. LiCalab relies on a broad network of local, regional and EU partners with expertise in Healthcare and Wellbeing, including local governments, care¬givers, research institutes, SMEs and multinationals. LiCalab is an accredited member of the European Network of Living Labs (ENoLL).
Head of Digital Health Ventures in HIT and co-founder of CARE
Hadas LewyHead of Digital Health Ventures in HIT and co-founder of CARE
Dr Hadas Lewy - Head of Digital Health Ventures in HIT and co-founder of CARE- Excellence Center for Applied Research and development of technologies for the Elderly in HIT. Responsible for strategic plan and collaboration models with healthcare organizations and Industry, establishment and management of research and development infrastructure in Digital Health including the unique labs : HEAL- Health Analytics Lab, MADE- Medical Assistive Design and Engineering Lab ,and the Living Lab- a smart home lab for homecare R&D. A Senior Lecturer Digital Medical Technologies department , serves as the head of the teaching committee of the unique academic (B.Sc.)program, in Digital Health that aims to educate the 21st century physicians in Digital Health and healthcare data analysts that can bridge the gap between the clinical world and the technological world, tackling data challenges with AI-tailored solutions. The program is affiliated by 7 leading hospitals and 3 HMOs in Israel She earned her PhD in the department of Human Genetics and Molecular Medicine at Sackler School of Medicine, Tel-Aviv University, Israel and then completed a Postdoc Fellowship in the department of Clinical Biochemistry and Molecular Medicine in the Medical School Pitie-Salpetriere. Paris, France. Her academic and industrial experience includes the development of medical devices and data analytics. In 2006 she established a company for home care service in oncology. In 2008 she joined Maccabi healthcare services where she established the International R&D Center, established collaboration between academia healthcare organizations and industry, founded and served as the CEO of NEVET Ltd –the R&D Company of Maccabi Group Holdings. The company developed products based on Maccabi's know-how. In 2015 she Co-founded CARE@HIT Excellence Center for Applied Research and Development of Technologies for the Elderly as a multidisciplinary meeting place and research center aim to address challenges faced by the older population. In 2017 she joined Clalit health services as the CRI Director of innovation and business development, established and managed the data innovation hub aim to develop and commercialize analytical products based on real world healthcare data that can be implemented in Clalit and other healthcare organizations worldwide. She has long experience in international collaborations in R&D including EU funded projects and the development of technologies and products for healthcare services that are compatible with the workflow and needs of healthcare systems.
Jan-Willem van de Loo
Policy and Scientific Officer at the European Commission in charge of cancer,
Jan-Willem van de LooPolicy and Scientific Officer at the European Commission in charge of cancer,
Jan-Willem van de Loo, Cancer Theme Lead since 2019, has been a Policy and Scientific Officer at the European Commission in charge of cancer, since 2003. He has extensive experience with project management, international cancer research & innovation policy activities and stakeholder interactions. He graduated in Biology at the University of Utrecht in 1991, after a year at the UW-Madison Medical School Graduate Program. He worked as a junior scientist on blood coagulation at Sanquin, Amsterdam and obtained his PhD in cell biology at the Centre for Human Genetics at the University of Leuven in 1999. He held three postdoctoral positions in cancer research, including a Marie-Curie postdoctoral fellowship at the European Institute of Oncology in Milan.